Considerations When Implementing Automated Methods into GxP Laboratories

Journal of Laboratory Automation

Volumn 10, Issue 3, 2005, Pages 182-191

  Webster, Gregory K ^a   Kotts, Laila ^a   Maloney, Todd D ^a  

^a PFIZER INC   (United States)

Author keywords

automated methods; GxP

Indexed keywords

AUTOMATION; DISSOLUTION; DRUG PRODUCTS PLANTS; MATERIALS HANDLING; RELIABILITY;

AUTOMATED METHODS; GOOD CLINICAL PRACTICES (GCP); PHARMACEUTICAL INDUSTRY; REGULATORY AGENCIES;

INDUSTRIAL LABORATORIES;

PREDNISONE; SALICYLIC ACID;

ACCURACY; ANALYTIC METHOD; CALCULATION; CONTROLLED STUDY; DRUG INDUSTRY; DRUG SOLUBILITY; GOOD CLINICAL PRACTICE; GOOD LABORATORY PRACTICE; GOOD MANUFACTURING PRACTICE; INTERMETHOD COMPARISON; LABORATORY AUTOMATION; LINEAR SYSTEM; MATERIALS HANDLING; MEDICAL DOCUMENTATION; PRACTICE GUIDELINE; QUALITATIVE ANALYSIS; QUALITY CONTROL; QUANTITATIVE ANALYSIS; RELIABILITY; REPRODUCIBILITY; REVIEW; SENSITIVITY AND SPECIFICITY; SEPARATION TECHNIQUE; STATISTICAL ANALYSIS; VALIDATION PROCESS;

EID: 20444461206     PISSN: 22110682     EISSN: 15402452     Source Type: Journal    
DOI: 10.1016/j.jala.2005.03.003     Document Type: Article

References (17)

1. Guideline on the Validation of Analytical Procedures: Methodology (1). International Conference on Harmonization of Technical Requirements for the Registration of Drugs for Human Use, Geneva, Switzerland, May 9, 1997.
2. VICH GL2. International Cooperation on Harmonization of Technical Requirements for Registration of Veterinary Medicinal Products, Brussels, Belgium, October 1998.
3. Code of Federal Regulations, Title 21, Foods and Drugs (U.S. Government Printing Office, Washington D.C., 1 April 1997), Part 211.
4. USP 25 (United States Pharmacopeial Convention, Rockville, Maryland, 2005).
5. Green J. M. Anal. Chem. 1996, 68, 305A–309A.
6. Swartz M. E. Krull I. S. Pharm. Technol. 1998, 22(3), 104–119.
7. Weiser W. E. Analytical validation. Pharm. Technol. 1998, 20–29.
8. Guidance for Industry: Analytical Procedures and Methods Validation Chemistry, Manufacturing and Controls Documentation. U.S. Food and Drug Administration, U.S. Government Printing Office: Washington, DC, 2000.
9. Bedson P. Sargent M. Accred. Qual. Assur. 1996, 1, 265–274.
10. Bansal S. K. Layloff T. Bush E. D. Hamilton M. Hankinson E. A. Landy J. S. Lowes S. Nasr M. M. St. Jean P. A. Shah V. P. AAPS Pharm. Sci. Tech. 2004, 5(1), Article 22.
11. Green J. M. Anal. Chem. 1996, 68, 305A–309A.
12. Webster G. K. Farrand D. A. Litchman M. A. J. of Process Analytical Chemistry 2003, 8(1), 11–17.
13. Scypinski S. Roberts D. O. Oates M. Etse J. Pharm. Technol. 2002, 84–88.
14. Furman W. B. Layloff T. Tetzlaff R. F. J. AOAC Int. 1994, 77, 1314–1318.
15. Bolton S. Pharmaceutical Statistics: Practical & Clinical Applications. 3rd ed.; Marcel Dekker: New York, 1997.
16. Seo P. R. Shah V. P. Polli J. E. Pharm. Dev. Tech. 2002, 7, 257–265.
17. Moore J. W. Flanner H. H. Pharm. Technol. 1996, 20(6), 64–74.